Xu, L.; Shao, F.; Luo, T.; Li, Q.; Tan, D.; Tan, Y.
Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma. Int. J. Mol. Sci. 2022, 23, 8489.
https://doi.org/10.3390/ijms23158489
AMA Style
Xu L, Shao F, Luo T, Li Q, Tan D, Tan Y.
Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma. International Journal of Molecular Sciences. 2022; 23(15):8489.
https://doi.org/10.3390/ijms23158489
Chicago/Turabian Style
Xu, Lei, Fengling Shao, Tengling Luo, Qijun Li, Dongmei Tan, and Yi Tan.
2022. "Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma" International Journal of Molecular Sciences 23, no. 15: 8489.
https://doi.org/10.3390/ijms23158489
APA Style
Xu, L., Shao, F., Luo, T., Li, Q., Tan, D., & Tan, Y.
(2022). Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma. International Journal of Molecular Sciences, 23(15), 8489.
https://doi.org/10.3390/ijms23158489